Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia [Phase 1]

View source ↗

Summary

A Phase I dose-escalation study of CAT-8015 (moxetumomab pasudotox) in participants with chronic leukemia; the trial was terminated and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia
• Small Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• CAT-8015 (moxetumomab pasudotox) (moxetumomab pasudotox)

Snippet

Sponsor: MedImmune LLC | Conditions: Leukemia, Lymphoma, Chronic Lymphocytic, Leukemia, Prolymphocytic Leukemia, Small | Phase 1 | Status: TERMINATED | Results posted: 2017-04-12